Top Companies in the Dental Drug Market
- Colgate-Palmolive
- Haleon/GSK
- Procter & Gamble
- Johnson & Johnson
- 3M
- Dentsply Sirona
- Septodont
- Ultradent Products
- VOCO GmbH
- Patterson Dental
- Henry Schein
- Kerr (Envista)
- GC Corporation
- Sunstar/GUM
- Regional & specialty dental pharmaceutical manufacturers and CDMOs
Market Growth
The global dental drug market size is calculated at US$ 9.07 billion in 2024, grew to US$ 9.68 billion in 2025, and is projected to reach around US$ 17.41 billion by 2034. The market is expanding at a CAGR of 6.75% between 2025 and 2034.
What are the Ongoing Trends in the Dental Drug Market?
- The emergence of growing health awareness and disposable incomes, and a rise in improved access to dental care, are acting as crucial growth factors in the overall investments and collaborations.
- In August 2025, Solventum Thailand, a global innovator in patient-centered healthcare solutions, ensured its longstanding partnership with DKSH (Thailand) Limited, Business Unit Healthcare, to advance dental access across Thailand.
- In May 2025, Dogwood Health Trust invested more than $85,000 in Patient Care Funds in dental care for western North Carolina.
- In January 2025, France-based Septodont made a strategic investment in Balanced Pharma Inc. (BPI), a North Carolina-based company, to foster the development of its new dental injection drugs.
Canada Dental Drug Market Trends
Canada’s developments in new specialty dental anesthesiology to accelerate access to dental care through public programs are driving its market expansion.
For this market,
- In October 2024, OraQ AI partnered with Patterson Dental Canada to launch its artificial intelligence (AI)-based clinical decision support tool to dental practices across Canada.
The Market Value Chain Analysis
R&D
Basically, this comprises advanced drug discovery approaches to detect dental needs, then preclinical research for efficacy and safety, and at the ned clinical studies with the required dose and post-market activities in the dental drug market.
Key Players: Procter & Gamble, Dentsply Sirona, and DMG Dental, etc.
Clinical Trials and Regulatory Approvals
After the successful preclinical stage, sponsors should conduct robust multi-phase clinical trials to investigate safety and efficacy, followed by a complete review by regulatory bodies, mainly India's Drugs Controller General of India (DCGI) or the U.S. Food and Drug Administration (FDA).
Key Players: Cairo University, King Abdulaziz University, Craig Miller, etc.
Patient Support and Services
The dental drug market encompasses a pre-treatment medical history review, including current medications, to assess drug interactions and allergies. This further gives a treatment plan, which comprises options and informed patient consent before medication is prescribed or administered.
Key Players: Life Vision Healthcare, Epitome Lifesciences, Pax Healthcare, etc.
Latest Announcements by Industry Leaders
- In June 2025, the Ivoclar Group and the MALO CLINIC collaborated, intending to evolve innovative dental treatment concepts. Markus Heinz, CEO at Ivoclar, said that this will boost product development, research, and training from the outset to develop innovative and practical solutions that sustainably accelerate everyday clinical practice for their customers.
- In April 2025, Medit, a global player in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, officially announced a strategic partnership. The jointers said this will show rigorous integration of Medit's expertise in intraoral scanning and open digital workflows with Graphy's groundbreaking material technology, like the world's first directly 3D-printed clear aligners.
What are the Recent Developments in the Dental Drug Market?
- In July 2025, Chinese 3D printing firm HeyGears launched its Multi-Material 3D printed one-piece dentures.
- In March 2025, Lithoz, based in Vienna, Austria, unveiled its new LithaBite alumina for the Additive Manufacturing of translucent orthodontic ceramic brackets.
- In February 2025, LuxCreo launched the 4D Bright Aligner, simultaneously accelerating orthodontic and aesthetic dental care.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
